Phosphatidylinositol 3-kinase-binding protein, PI3KAP/XB130, is required for cAMP-induced amplification of IGF mitogenic activity in FRTL-5 thyroid cells

Molecular Endocrinology

Volumn 26, Issue 6, 2012, Pages 1043-1055

  Yamanaka, Daisuke ^a,c   Akama, Takeshi ^a,b   Fukushima, Toshiaki ^a,d   Nedachi, Taku ^a,e   Kawasaki, Chie ^a   Chida, Kazuhiro ^a   Minami, Shiro ^c   Suzuki, Koichi ^b   Hakuno, Fumihiko ^a   Takahashi, Shin Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e TOYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE BINDING PROTEIN; PROTEIN KINASE P60; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FIBROBLAST; GENE AMPLIFICATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RAT; THYROID CELL;

ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL PROLIFERATION; CYCLIC AMP; DNA REPLICATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MITOGENS; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR; SEQUENCE ANALYSIS, DNA; SRC-FAMILY KINASES; THYROID GLAND; THYROTROPIN;

RATTUS;

EID: 84861208388     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1349     Document Type: Article

References (40)

1. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, PittsMeek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
2. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulinlike growth factors in embryonic and postnatal growth. Cell 75: 73-82
3. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
4. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
5. Qureshi FG, Tchorzewski MT, Duncan MD, Harmon JW 1997 EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells. J Surg Res 69:354-358
6. Stiles CD, Capone GT, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ 1979 Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76:1279-1283
7. Stewart AJ, Johnson MD, May FE, Westley BR 1990 Role of insulinlike growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178
8. Itagane Y, Inada H, Fujita K, Isshiki G 1991 Interactions between steroid hormones and insulin-like growth factor-I in rabbit chondrocytes. Endocrinology 128:1419-1424
9. Meroni SB, Riera MF, Pellizzari EH, Galardo MN, Cigorraga SB 2004 FSH activates phosphatidylinositol 3-kinase/protein kinase B signaling pathway in 20-day-old Sertoli cells independently of IGF-I. J Endocrinol 180:257-265
10. Tramontano D, Moses AC, Veneziani BM, Ingbar SH 1988 Adenosine 3_,5_-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. Endocrinology 122:127-132
11. Takahashi S, Conti M, Van Wyk JJ 1990 Thyrotropin potentiation of insulin-like growth factor-I dependent deoxribonucleic acid synthesis in FRTL-5 cells: mediation by an autocrine amplification factor(s). Endocrinology 126:736-745
12. Cheung NW, Lou JC, Boyages SC 1996 Growth hormone does not increase thyroid size in the absence of thyrotropin: a study in adults with hypopituitarism. J Clin Endocrinol Metab 81:1179-1183
13. Clément S, Refetoff S, Robaye B, Dumont JE, Schurmans S 2001 Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-Ir receptor in the thyroid gland. Endocrinology 142: 5131-5139
14. Cheung NW, Boyages SC 1997 The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46:545-549
15. Ambesi-Impiombato FS, Parks LA, Coon HG 1980 Culture of hormonedependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA 77:3455-3459
16. Takahashi S, Conti M, Prokop C, Van Wyk JJ, Earp 3rd HS 1991 Thyrotropin and insulin-like growth factor I regulation of tyrosine phosphorylation in FRTL-5 cells. Interaction between cAMP-dependent and growth factor-dependent signal transduction. J Biol Chem 266:7834-7841
17. Nedachi T, Akahori M, Ariga M, Sakamoto H, Suzuki N, Umesaki K, Hakuno F, Takahashi SI 2000 Tyrosine kinase and phosphatidylinositol 3-kinase activation are required for cyclic adenosine 3_,5_-monophosphate-dependent potentiation of deoxyribonucleic acid synthesis induced by insulin-like growth factor-I in FRTL-5 cells. Endocrinology 141:2429-2438
18. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR 1989 Sitedirected mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59
19. Kane S, Sano H, Liu SC, Asara JM, Lane WS, Garner CC, Lienhard GE 2002 A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 277:22115-22118
20. Xu J, Bai XH, Lodyga M, Han B, Xiao H, Keshavjee S, Hu J, Zhang H, Yang BB, LiuM2007 XB130, a novel adaptor protein for signal transduction. J Biol Chem 282:16401-16412
21. Lodyga M, Bai XH, Mourgeon E, Han B, Keshavjee S, LiuM2002 Molecular cloning of actin filament-associated protein: a putative adaptor in stretch-induced Src activation. Am J Physiol Lung Cell Mol Physiol 283:L265-L274
22. Grozovsky R, Morales MM, Carvalho DP 2007 Biphasic modulation of insulin receptor substrate-1 during goitrogenesis. Braz J Med Biol Res 40:679-686
23. Lodyga M, Bai XH, Kapus A, LiuM2010 Adaptor protein XB130 is a Rac-controlled component of lamellipodia that regulates cell motility and invasion. J Cell Sci 123:4156-4169
24. Fukushima T, Nedachi T, Akizawa H, Akahori M, Hakuno F, Takahashi S 2008 Distinct modes of activation of phosphatidylinositol 3-kinase in response to cyclic adenosine 3_, 5_-monophosphate or insulin-like growth factor I play different roles in regulation of cyclin D1 and p27Kip1 in FRTL-5 cells. Endocrinology 149:3729-3742
25. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC 1993 SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778
26. Baisden JM, Qian Y, Zot HM, Flynn DC 2001 The actin filamentassociated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity. Oncogene 20:6435-6447
27. Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC 2004 Protein kinase C_ activates c-Src and induces podosome formation via AFAP-110. Mol Cell Biol 24:7578-7597
28. Han B, Bai XH, Lodyga M, Xu J, Yang BB, Keshavjee S, Post M, Liu M 2004 Conversion of mechanical force into biochemical signaling. J Biol Chem 279:54793-55801
29. Lodyga M, De Falco V, Bai XH, Kapus A, Melillo RM, Santoro M, Liu M 2009 XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. Oncogene 28:937-949
30. Uyttersprot N, Costagliola S, Dumont JE, Miot F 1999 Requirement for cAMP-response element (CRE) binding protein/CRE modulator transcription factors in thyrotropin-induced proliferation of dog thyroid cells in primary culture. Eur J Biochem 259: 370-378
31. Obara Y, Labudda K, Dillon TJ, Stork PJ 2004 PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 117:6085-6094
32. Schmitt JM, Stork PJ 2002 PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol Cell 9:85-94
33. Guappone AC, Weimer T, Flynn DC 1998 Formation of a stable src-AFAP-110 complex through either an amino-terminal or a carboxyterminal SH2-binding motif. Mol Carcinog 22:110-119
34. Kong M, Mounier C, Wu J, Posner BI 2000 Epidermal growth factor-induced phosphatidylinositol 3-kinase activation and DNA synthesis. Identification of Grb2-associated binder 2 as the major mediator in rat hepatocytes. J Biol Chem 275:36035-36042
35. Lawlor MA, Feng X, Everding DR, Sieger K, Stewart CE, Rotwein P 2000 Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol Cell Biol 20:3256-3265
36. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR 1994 Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14:4902-4911
37. Jones SM, Kazlauskas A 2001 Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat Cell Biol 3:165-172
38. Alam H, Maizels ET, Park Y, Ghaey S, Feiger ZJ, Chandel NS, Hunzicker-Dunn M 2004 Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/ AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem 279: 19431-19440
39. Xia X, Serrero G 1999 Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors. J Cell Physiol 178:9-16
40. Adashi EY, Resnick CE 1984 Forskolin-induced differentiation of cultured rat granulosa cells: new evidence for an intermediary role of adenosine 3_,5_-monophosphate in the mechanism of action of follicle-stimulating hormone. Endocrinology 115:183-190